Sign up to save your podcasts
Or
Share Breakthrough Research in Autoimmune Skin Treatment by Scinai Immunotherapeutics
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Breakthrough Research in Autoimmune Skin Treatment by Scinai Immunotherapeutics
Scinai Immunotherapeutics, known for their breakthrough PC111 research, is advancing a non-immunosuppressive treatment for severe autoimmune skin conditions by blocking keratinocyte apoptosis. Dr. Roberta Lotti's work on the anti-Fas Ligand monoclonal antibody was recognized with the 'Oscar of Italian Dermatology'.
View all episodes
By NewsRampScinai Immunotherapeutics, known for their breakthrough PC111 research, is advancing a non-immunosuppressive treatment for severe autoimmune skin conditions by blocking keratinocyte apoptosis. Dr. Roberta Lotti's work on the anti-Fas Ligand monoclonal antibody was recognized with the 'Oscar of Italian Dermatology'.